RT Conference Proceedings
T1 Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177
A1 Yoshino, Takayuki
A1 Kim, Tae Won
A1 Yong, Wei Peng
A1 Shiu, Kai-Keen
A1 Jensen, Benny Vittrup
A1 Jensen, Lars Henrik
A1 Smith, Denis
A1 Garcia-Carbonero, Rocio
A1 Alcaide-Garcia, Julia
A1 Gibbs, Peter
A1 De la Fouchardiere, Christelle
A1 Rivera, Fernando
A1 Elez, Elena
A1 Bendell, Johanna
A1 Le, Dung T.
A1 Yang, Ping
A1 Farooqui, Mohammed
A1 Marinello, Patricia
A1 Diaz, Luis A.
A1 Andre, Thierry
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-07-26
LK https://hdl.handle.net/10668/24354
UL https://hdl.handle.net/10668/24354
LA en
DS RISalud
RD Apr 6, 2025